We characterized Fc receptor III (FcR III) on human neutrophils and found it to be heavily glycosylated and polymorphic. In some individuals, FcR III that had been digested with Nglycanase appeared after SDS-PAGE under 
immunophagocytosis both in vitro (2) and in vivo (3, 4) . FcR III from human neutrophils appears as a broad band from 50 to 73 kD after SDS-PAGE, and has been characterized as a complex sialoglycoprotein (1, 2, 5) . In previous studies, we determined that the electrophoretic heterogeneity of neutrophil FcR III is due, in part, to abundant N-linked carbohydrate (2) . We also noted a previously undescribed structural polymorphism of neutrophil FcR III. After digestion with N-glycanase, FcR III from neutrophils ofsome individuals appeared after SDS-PAGE under reducing conditions as two bands with apparent molecular masses of 33 and 29 kD. FcR III from neutrophils of other individuals appeared as a single band at 33 kD.
Antigenic polymorphisms of FcR III have been reported previously. Lalezari (6-8) described a neutrophil antigen (NA) system with three allotypes defined by alloantisera. Werner et al. (9) , more recently demonstrated by indirect immunofluorescence and sequential immunoprecipitation using monoclonal antibodies (MAbs) 3G8, Leu 11, and Gran 11 that NA epitopes were allotypic forms of FcR III. Whereas MAbs 3G8 and Leu 11 recognized FcR III on neutrophils from all individuals, MAb Gran 11 (anti-NA 1) recognized FcR III on neutrophils from only 46% of individuals (6, 7) . Neutrophil surface components bearing NA epitopes are target antigens in autoimmune neutropenia (10) (11) (12) (13) .
In this report, we describe the relationship between the previously reported structural and antigenic polymorphisms of FcR III and demonstrate that differences between the various structural types of neutrophil FcR III reflect differences at the level of primary protein structure.
Methods
Preparation ofperipheral blood neutrophils. Blood was obtained from normal human volunteers, anticoagulated with acid-citrate-dextrose, and then subjected to centrifugation on Hypaque-Ficoll (density 1.077) to separate neutrophils and erythrocytes from mononuclear cells (14) . Neutrophils were then separated from erythrocytes by sedimentation with 6% dextran (14) , and washed three times with phosphate (10 mM)-buffered saline, pH 7.4. Preparations usually contained > 95% neutrophils as determined by Wright staining.
Monoclonal antibodies. The cell line producing MAb 3G8 (murine Alloantisera. Polyclonal anti-NAI and anti-NA2 alloantisera, obtained from pooled blood oftransfused patients and pregnant women, were generously provided by Dr. Parviz Lalezari (Albert Einstein Medical Center, Bronx, NY). Alloantisera and normal human serum were subjected to centrifugation at 160,000 g for 30 min to remove aggregates.
Immunoprecipitation. Purified human neutrophils (3.0-5.0 X 10' cells) were surface-labeled with 125I using lodogen (100 ag/tube) ( To measure binding of radiolabeled MAb 3G8, neutrophils (0.5-1.0 X 106 cells/ml) were incubated at 4°C with equal volumes of '251-labeled Fab fragments of MAb 3G8 (2.5 gg/ml) and either PBS containing 1.0 mg/ml BSA (PBS/BSA) or unlabeled MAb (1.0 mg/ml). After 30 min, cells were suspended in 0.5 ml cold PBS/BSA, layered over 0.5 ml Versilube F50 silicon oil (General Electric, Waterford, NY) in 1.5-ml polypropylene microfuge tubes, and centrifuged for 5 min at 10,000 g. After aspirating the aqueous and oil phases, the bottoms of tubes containing cell pellets were excised and subjected to gamma counting. Specific binding was determined by subtracting radioactivity that became cell-associated in the presence of excess unlabeled antibody from total radioactivity.
Results
FcR III on human neutrophils appears to be polymorphic. Treatment of immunoprecipitated FcR III with N-glycanase, which cleaves N-linked oligosaccharides at sugar-amino acid linkages, changed its electrophoretic mobility under reducing conditions from a broad band extending from 50 to 73 kD to either two major bands with apparent molecular masses of 33 and 29 kD (Fig. 1) We next attempted to determine the basis for the apparent structural heterogeneity of FcR III. We considered four possibilities. First, the two-band structural type may represent degradation products of the one-band structural types. According to the manufacturer, N-glycanase copurifies with a zinc-dependent protease. Accordingly, removal of N-linked sugars from FcR III with N-glycanase always was carried out in the presence of 1,1O phenanthroline, an inhibitor of zinc-dependent proteases. Patterns observed after N-glycanase treatment of FcR III from each individual tested were consistent from experiment to experiment. Each individual was studied at least three times. Patterns were not affected by prolonged incubation nor by an excess of N-glycanase. Furthermore, N-glycanase did not cleave BSA (data not shown). Therefore, it is unlikely that the difference between structural types is due to proteolysis.
Another possible explanation for differences between structural types of FcR III is the presence of an interchain disulfide bond in the two-band structural type that is absent in the one-band structural types. SDS-PAGE under nonreducing conditions of FcR III treated with N-glycanase revealed decreased apparent molecular masses of each structural type (Fig. 3 ). An increase in apparent Mr following reduction suggests the presence of intramolecular disulfide bonds (19), but does not explain the observed differences between the structural types. Differences between structural types were observed after SDS-PAGE under both reducing and nonreducing con- ditions. It should be noted that a minor band was observed on nearly all gels. Under reducing conditions, it migrated slightly faster, while under nonreducing conditions, it migrated slightly slower than did the major bands (Figs. 2 and 3) . A third possibility is that the structural types differ in degree of O-linked glycosylation. Although we did not exclude this possibility, the differences in patterns seen after SDS-PAGE are not typical of those seen with differences in glycosylation.
Finally, differences between structural types may reflect differences in primary protein structure. Using peptide mapping, we examined relationships between different structural types and relationships of bands within each structural type. Shown in Fig. 4 are peptide maps from two representative individuals. The 33-kD band in the two-band structural type and the 33-kD band in the single 33-kD band structural type yielded similar peptide maps. Peptide mapping of the 29-kD band of the two-band structural type exhibited a pattern that was similar to that ofthe 33-kD band. However, a peptide with an approximate Mr of 23 kD appeared to be missing in all three individuals examined. These results suggest that differences between FcR III structural types reflect differences at the level of primary protein structure.
Structural differences among FcR III core protein(s) are related to differences in reactivity with MAb Gran II and anti-NA-I and anti-NA-2 alloantisera. Previous work by Werner et al. (9) and by Lalezari (6) (7) (8) demonstrated that FcR III on human neutrophils exhibits antigenic heterogeneity. Both MAb 3G8 and MAb Gran 11 precipitated a 50-73-kD protein (1, 9) . However, MAb 3G8 recognized FcR III on neutrophils from all individuals, whereas MAb Gran 11 recognized FcR III on neutrophils from -50% of individuals. Monoclonal antibody Gran 11 recognizes NA I of the neutrophil-specific, biallelic NA antigen system (9) . In a normal caucasian population, NA 1 and NA2 were found on neutrophils from 46 and 88% of individuals, respectively (6, 7).
Analyses by flow cytometry and/or fluorescence microscopy were carried out on cells from 22 individuals. Neutrophils from all individuals reacted with MAb 3G8 (Fig. 5 and Table I ). Reactivity of neutrophils with MAb Gran 11 corre- lated with the appearance of the 29-kD band in both the single 29 kD-band structural type and the two-band structural type. However, the relative fluorescence intensity of cells that yielded only the 29-kD band was greater than that of cells that yielded both the 29-and 33-kD' bands (Fig. 5) . FcR Reactivity of neutrophils with anti-NA alloantisera also correlated with differences in structural types (Table I) . FcR III on neutrophils that reacted with both anti-NA 1 and anti-NA2 alloantisera yielded the two-band structural type after digestion with N-glycanase. FcR FITC-labeled goat anti-human immunoglobulin for 30 min at 4VC. Neutrophils were then examined using fluorescence microscopy and/ or flow cytometry. # (+) Indicates that > 20% of the neutrophils reacted with the antibody and (-) indicates that < 3% of neutrophils reacted with the antibody.
were due to differences in glycosylation. Sequential immunoprecipitation (Fig. 6 ) revealed that although both MAbs 3G8 and Gran 11 recognized undigested FcR III of the two-band structural type (lanes 1 and 3, respectively), only MAb 3G8 recognized undigested FcR III of the single 33 kD-band structural type (lane 9). After digestion with N-glycanase, MAbs 3G8 and Gran 11 also recognized the 29-kD band in the twoband structural type (lanes 5 and 7, respectively). Although MAb 3G8 appeared to recognize the 33-kD band noted after N-glycanase digestion of the single 33-kD band structural type (lane 13), faint 33-kD bands also appeared after incubating cell (Figs. 2 and  3 ). This additional band may represent a polypeptide that is noncovalently associated with FcR III on the surface ofhuman neutrophils. Alternatively, the minor band may reflect incomplete digestion of FcR III by N-glycanase, the presence of variable amounts of O-linked oligosaccharides, or an artifact.
Peptide mapping by limited proteolysis with S. aureus V8 protease revealed differences between the structural types of neutrophil FcR III (Fig. 4) . Peptide maps ofthe 33-kD band in the single 33-kD band and two-band structural types ofFcR III were similar. Peptide mapping of the 29-kD band yielded a pattern that was similar to that of the 33-kD band, except that a 23-kD peptide was missing. Although it is possible that the "missing" 23 kD peptide simply was not radioiodinated because a tyrosine residue was rendered inaccessible by some posttranslational effect, these results are consistent with the conclusion that the 33-kD polypeptide differs from the 29-kD polypeptide with respect to its amino acid sequence.
Sequential immunoprecipitation of FcR III as well as fluorescence microscopy and flow cytometry showed that there were differences in reactivity with MAb Gran 11 among the structural types (Figs. 5 and 6 ). Both MAbs 3G8 and Gran 11 recognized undigested FcR III of the two-band structural type as well as the 29 kD band noted after digestion with N-glycanase. Only MAb 3G8 recognized undigested FcR III of the single 33 kD-band structural type. Differences in reactivity with MAbs also were probably due to differences in primary protein structure.
Neutrophil FcR III of the different structural types also exhibited different reactivities with anti-NA alloantisera (Table I) . Individuals whose neutrophils expressed the twoband structural type appeared to be heterozygous for both NA1 and NA2, whereas individuals whose neutrophils expressed the single 33-kD band structural type appeared to be homozygous for NA2. The two individuals whose neutrophils expressed the single 29-kD band structural type appeared to be homozygous for NA 1. As would be expected, cells from NA 1-NAl homozygotes bound more MAb Gran 11 than did cells from NA I-NA2 heterozygotes (Fig. 6) . Thus, the structural polymorphism of FcR .111 correlates with the neutrophil-specific NA antigen system. FcR III has been cloned recently from human placenta, sequenced, and found to be the product of a single gene (20) . Unlike other FcRs, FcR III is anchored to the membrane via a glycosyl-phosphatidylinositol linkage (20) (21) (22) . In light ofthese recently reported observations, and the results of our own experiments, it is possible that there are two alleles ofthe FcR III gene, one which encodes a 29-kD polypeptide and another which encodes a 33-kD polypeptide. It also is possible that the 29-and 33-kD polypeptides are products of alternatively spliced transcripts from a single gene.
Polymorphisms have been reported for other Fc receptors. Human FcR II, a 40-kD protein on neutrophils, monocytes, and platelets, as well as FcR 1, a 72-kD protein on monocytes and macrophages have been shown to be polymorphic (23) (24) (25) (26) (27) . Although the functional significance of structural polymorphisms ofFcR III is unknown, a wide range in rates of Fc-mediated clearance of antigen-antibody complexes has been demonstrated. Prolonged Fc-mediated clearance of antigen-antibody complexes has been demonstrated in systemic lupus erythematosus (28, 29) , Sjogrens syndrome (30), dermatitis herpetiformis (31) , and normal individuals with the HLA-B8/DRw3 haplotype (31) . Because of the role played by FcR III in mediating immunophagocytosis in vivo (3, 4) , it is possible that differences in rates of clearance of circulating immune complexes are related to structural polymorphisms of FcR III.
